The 53rd Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD)

Invited speakers and topics

Type 1 diabetes

Jorma Ilonen, University of Turku, Finland – Prediction of T1D – genes, autoantibodies and heterogeneity
Riitta Lahesmaa, University of Turku, Finland – Early signs of T1D

Riitta Veijola, University of Oulu, Finland – Prevention of type 1 diabetes
Chantal Mathieu, KU Leuven, Belgium – New molecular mechanisms of T1D – basis for prevention

Päivi Keskinen, Tampere University Hospital, Finland – Treatment and monitoring of type 1 diabetes, current view and future prospects
Mark Peakman, King’s College Hospital, UK – Immunotherapy in T1D

Mikael Knip, University of Helsinki, Finland – Microbiome and type 1 diabetes
Malin Flodström Tullberg, Karolinska institute, Sweden – Viruses and type 1 diabetes
Arno Hänninen, University of Turku, Finland – Effect of gut dysbiosis to the development of autoimmunity

Type 2 diabetes

Ele Ferranini, University of Pisa, Italy – SGLT2 inhibitors: cardiovascular outcomes
Markku Laakso, University of Eastern Finland, Finland – Statins and risk of diabetes

Kirsi Pietiläinen, University of Helsinki, Finland – Obesity and type 2 diabetes
Filip Knop, University of Copenhagen, Denmark – The endocrine gut and its involvement in glucose homeostasis

Tina Vilsbøll, University of Copenhagen, Denmark – Diabetes and cardiovascular disease: glucagon-like peptide-1 based therapies
Pirjo Nuutila, University of Turku, Finland – GLP-1 receptor based detection of beta cells

Merja Laine, University of Helsinki, Finland – Physical activity in young adulthood and risk of type 2 diabetes later in life
Kumail Motiani, University of Turku, Finland – Effects of short-term exercise training on intestinal metabolism and gut microbiota

Award lecturers

Valdemar Grill, Norwegian University of Science and Technology, Trondheim, Norway – Friends and foes of the pancreatic beta cell – implications for treatment

Olle Korsgren, Uppsala University, Sweden – On the etiology of Type 1 Diabetes: lessons learned from the human pancreas

Pål Njölstad, University of Bergen, Norway – Type 2 diabetes –
Using monogenic diabetes for precision medicine in childhood diabetes